1-4 of 4
Gary Acton
Close
Sort by
Journal Articles

Ongoing Results of a Phase 1B/2 Dose-Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible Bruton'S Tyrosine Kinase Inhibitor, Vecabrutinib, in B-Cell Malignancies

John N. Allan, MD, Krish Patel, MD, Anthony R. Mato, MDMSCE, William G. Wierda, MD PhD, Javier Pinilla Ibarz, MD PhD, Michael Y. Choi, MD, Susan M. O'Brien, MD, Jeff P. Sharman, MD, Mazyar Shadman, MD, Douglas E Gladstone, MD, Matthew S. Davids, MD, John M. Pagel, MD PhD DSc, Renee Ward, MD PhD, Gary Acton, MD, Pietro Taverna, PhD, Judith A. Fox, PhD, Richard R. Furman, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3041.
https://doi.org/10.1182/blood-2019-126286
Published: 2019
Journal Articles

Cancer-Selective Targeting of the NF-κB Survival Pathway in Multiple Myeloma with the GADD45β/MKK7 Inhibitor, DTP3

Laura Tornatore, Gary Acton, Nigel Adams, Elizabeth A Campbell, James Kelly, Richard M Szydlo, BSc, PhD, Mike Tarbit, Salina Bannoo, Daniel D'Andrea, Daria Capece, Annamaria Sandomenico, Julian Dyson, Antonio Leonardi, Christoph Driessen, Menotti Ruvo, Ishara Anees, Metod Oblak, Sheena Quaid, Magda J Al-Obaidi, Holger Auner, Reuben Benbenjamin, Richard S Kaczmarski, Martin F Kaiser, Atul Mehta, Heather E Oakervee, Stephen A Schey, Ashutosh Wechalekar, Jane F. Apperley, MD, Guido Franzoso
Journal: Blood
Blood (2015) 126 (23): 868.
https://doi.org/10.1182/blood.V126.23.868.868
Published: 2015
Journal Articles

Improved Survival in Patients with First Relapsed or Refractory Acute Myeloid Leukemia (AML) Treated with Vosaroxin Plus Cytarabine Versus Placebo Plus Cytarabine: Results of a Phase 3 Double-Blind Randomized Controlled Multinational Study (VALOR)

Farhad Ravandi, MD, Ellen Ritchie, MD, Hamid Sayar, MD, Jeffrey Lancet, MD, Michael D. Craig, MD, Norbert Vey, MD, Stephen A. Strickland, MD, Gary Schiller, MD, Elias Jabbour, MD, Harry P. Erba, MD PhD, Arnaud Pigneux, MD, Heinz-August Horst, MD, Christian Recher, MD, Virginia M. Klimek, MD, Jorge Cortes, MD, Eric J. Feldman, MD, Adam R. Craig, MD PhD, Judith A. Fox, PhD, Renee Ward, MD PhD, Jennifer Smith, PhD, Gary Acton, MD, Cyrus Mehta, PhD, Hagop M. Kantarjian, MD, Robert K Stuart, MD
Journal: Blood
Blood (2014) 124 (21): LBA-6.
https://doi.org/10.1182/blood.V124.21.LBA-6.LBA-6
Published: 2014
Journal Articles

Relapsed and Refractory Acute Myeloid Leukemia (AML) Treated with AS1411 and Cytarabine: A Randomized Phase II Trial.

Robert Kenneth Stuart, MD, Gary Acton, AS1411-201 Investigator Group
Journal: Blood
Blood (2008) 112 (11): 1935.
https://doi.org/10.1182/blood.V112.11.1935.1935
Published: 2008